Suchergebnisse - "Osimertinib"

PubPharm (2.537)

1

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations : Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

enthalten in: JCO precision oncology | 2024

von Chen, M. | Song, Z. | Yu, H. | +19

2

Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer

enthalten in: Cancer letters | 2024

von Han, R. | Lin, C. | Lu, C. | +10

3

Assessing EGFR-mutated NSCLC with bone metastasis : Clinical features and optimal treatment strategy

enthalten in: Cancer medicine | 2024

von Chen, W. | Cheng, W. | Chen, C. | +6

4

Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Remon, J. | Besse, B. | Aix, S. | +19

5

DB-1310, an ADC comprised of a novel anti-HER3 antibody conjugated to a DNA topoisomerase I inhibitor, is highly effective for the treatment of HER3-positive solid tumors

enthalten in: Journal of translational medicine | 2024

von Li, X. | Yao, J. | Qu, C. | +6

6

Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Lee, E. | Oh, S. | Lee, Y. | +13

7

ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts

enthalten in: Cancer research | 2024

von Hu, B. | Wiesehöfer, M. | de Miguel, F. | +17

8

The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients : the challenge is open for new therapeutic strategies

enthalten in: Critical reviews in oncology/hematology | 2024

von Ferro, A. | Marinato, G. | Mulargiu, C. | +4

9

Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients

enthalten in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 2024

von Zhao, J. | Yan, D. | Li, Y. | +5

10

A Path to Persistence after EGFR Inhibition

enthalten in: Cancer research | 2024

von Rumde, P. | Burns, T.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[254]